(Q36868426)

16 August 2017

1 reference

title

Recent advances in the neuropathology of multiple sclerosis (English)

1 reference

16 August 2017

Stadelmann C

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

163

1 reference

16 August 2017

issue

6-7

1 reference

16 August 2017

page(s)

657-661

1 reference

Extensive cortical remyelination in patients with chronic multiple sclerosis.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Thalamic neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Chemical pathology of acute demyelinating lesions and its correlation with disability

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Axonal damage in acute multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Why does remyelination fail in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Immunopathogenesis and immunotherapy of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

In vivo imaging of axonal degeneration and regeneration in the injured spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Evidence for pathogenic heterogeneity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

In vivo imaging of the diseased nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Remyelination is extensive in a subset of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Multiple sclerosis: remyelination of nascent lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Grey Matter Pathology in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990475-0

7 January 2021

10.1016/S0035-3787(07)90475-0

Identifiers

DOI

1 reference

16 August 2017

1 reference